|
1
|
Pu Z, Yuan X, Zhang X, Chen Q and Xie H:
Meta-analysis on the association between CYP2D6*10 gene
polymorphism and disease free survival of breast cancer patients
receiving tamoxifen treatment in Asia. Bangladesh J Pharmacol.
9:652–662. 2014. View Article : Google Scholar
|
|
2
|
Li Z and Kang Y: Emerging therapeutic
targets in metastatic progression: A focus on breast cancer.
Pharmacol Ther. 161:79–96. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chung SS and Vadgama JV: Curcumin and
epigallocatechin gallate inhibit the cancer stem cell phenotype via
down-regulation of STAT3-NFκB signaling. Anticancer Res. 35:39–46.
2015.PubMed/NCBI
|
|
4
|
Ramachandran C and You W: Differential
sensitivity of human mammary epithelial and breast carcinoma cell
lines to curcumin. Breast Cancer Res Treat. 54:269–278. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li YB, Gao JL, Zhong ZF, Hoi PM, Lee SM
and Wang YT: Bisdemethoxycurcumin suppresses MCF-7 cells
proliferation by inducing ROS accumulation and modulating
senescence-related pathways. Pharmacol Rep. 65:700–709. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramachandran C, Rodriguez S, Ramachandran
R, Nair Raveendran PK, Fonseca H, Khatib Z, Escalon E and Melnick
SJ: Expression profiles of apoptotic genes induced by curcumin in
human breast cancer and mammary epithelial cell lines. Anticancer
Res. 25:3293–3302. 2005.PubMed/NCBI
|
|
7
|
Basnet P and Skalko-Basnet N: Curcumin: An
anti-inflammatory molecule from a curry spice on the path to cancer
treatment. Molecules. 16:4567–4598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Y, Shu W, Chen W, Wu Q, Liu H and Cui
G: Curcumin, both histone deacetylase and p300/CBP-specific
inhibitor, represses the activity of nuclear factor kappa B and
Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol. 101:427–433.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Yu J, Cui R, Lin J and Ding X:
Curcumin in treating breast cancer: A review. J Lab Autom.
21:723–731. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hatcher H, Planalp R, Cho J, Torti FM and
Torti SV: Curcumin: From ancient medicine to current clinical
trials. Cell Mol Life Sci. 65:1631–1652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin YG, Kunnumakkara AB, Nair A, Merritt
WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM,
Lutgendorf SK, et al: Curcumin inhibits tumor growth and
angiogenesis in ovarian carcinoma by targeting the nuclear
factor-kappaB pathway. Clin Cancer Res. 13:3423–3430. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rengarajan T, Nandakumar N, Rajendran P,
Haribabu L, Nishigaki I and Balasubramanian MP: D-pinitol promotes
apoptosis in MCF-7 cells via induction of p53 and Bax and
inhibition of Bcl-2 and NF-κB. Asian Pac J Cancer Prev.
15:1757–1762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim KC, Baek SH and Lee C:
Curcumin-induced downregulation of Axl receptor tyrosine kinase
inhibits cell proliferation and circumvents chemoresistance in
non-small lung cancer cells. Int J Oncol. 47:2296–2303. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Su J, Feng S, Wang L, Yin X, Yan J
and Wang Z: Antitumor activity of curcumin is involved in
down-regulation of YAP/TAZ expression in pancreatic cancer cells.
Oncotarget. 7:79076–79088. 2016.PubMed/NCBI
|
|
18
|
Sha J, Li J, Wang W, Pan L, Cheng J, Li L,
Zhao H and Lin W: Curcumin induces G0/G1 arrest and apoptosis in
hormone independent prostate cancer DU-145 cells by down regulating
Notch signaling. Biomed Pharmacother. 84:177–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iqbal B, Ghildiyal A, Sahabjada, Singh S,
Arshad M, Mahdi AA and Tiwari S: Antiproliferative and apoptotic
effect of curcumin and TRAIL (TNF Related Apoptosis inducing
Ligand) in chronic myeloid leukaemic cells. J Clin Diagn Res.
10:XC01–XC05. 2016.PubMed/NCBI
|
|
20
|
Somasundaram S, Edmund NA, Moore DT, Small
GW, Shi YY and Orlowski RZ: Dietary curcumin inhibits
chemotherapy-induced apoptosis in models of human breast cancer.
Cancer Res. 62:3868–3875. 2002.PubMed/NCBI
|
|
21
|
Tor YS, Yazan LS, Foo JB, Armania N, Cheah
YK, Abdullah R, Imam MU, Ismail N and Ismail M: Induction of
apoptosis through oxidative stress-related pathways in MCF-7, human
breast cancer cells, by ethyl acetate extract of Dillenia
suffruticosa. BMC Complement Altern Med. 14:552014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oida K, Matsuda A, Jung K, Xia Y, Jang H,
Amagai Y, Ahn G, Nishikawa S, Ishizaka S, Jensen-Jarolim E, et al:
Nuclear factor-ĸB plays a critical role in both intrinsic and
acquired resistance against endocrine therapy in human breast
cancer cells. Sci Rep. 4:40572014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Colomer C, Marruecos L, Vert A, Bigas A
and Espinosa L: NF-κB members left home: NF-κB-independent roles in
cancer. biomedicines. 5:pii: E26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: Evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
|
